Truist Financial Issues Positive Forecast for Ardent Health (NYSE:ARDT) Stock Price

Ardent Health (NYSE:ARDT) had its target price increased by equities researchers at Truist Financial from $12.00 to $13.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s price target would indicate a potential upside of 16.01% from the company’s previous close.

Several other analysts also recently issued reports on the stock. Royal Bank Of Canada decreased their price objective on shares of Ardent Health from $13.00 to $12.00 and set an “outperform” rating for the company in a research note on Thursday, July 9th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $13.00 target price on shares of Ardent Health in a research note on Thursday. Wall Street Zen lowered Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Guggenheim raised their price objective on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday. Finally, UBS Group increased their price target on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Seven research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $13.54.

Ardent Health Trading Up 0.4%

ARDT traded up $0.05 during trading on Thursday, reaching $11.21. The company had a trading volume of 150,031 shares, compared to its average volume of 463,287. The stock has a market cap of $1.61 billion, a P/E ratio of 20.43, a PEG ratio of 2.53 and a beta of 0.70. The business has a 50 day simple moving average of $9.89 and a 200-day simple moving average of $9.46. Ardent Health has a 52 week low of $7.71 and a 52 week high of $15.48. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62.

Ardent Health (NYSE:ARDT) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). Ardent Health had a net margin of 1.22% and a return on equity of 10.45%. The firm had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, equities analysts anticipate that Ardent Health will post 1.06 EPS for the current fiscal year.

Insider Buying and Selling at Ardent Health

In other Ardent Health news, CFO Alfred Lumsdaine bought 10,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average price of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the purchase, the chief financial officer directly owned 329,183 shares in the company, valued at $2,900,102.23. This trade represents a 3.13% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.90% of the company’s stock.

Institutional Trading of Ardent Health

Hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Ardent Health by 103.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after purchasing an additional 7,182 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after buying an additional 724,841 shares during the last quarter. Jane Street Group LLC boosted its holdings in Ardent Health by 235.1% in the first quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock worth $790,000 after purchasing an additional 40,318 shares during the period. Acadian Asset Management LLC increased its holdings in shares of Ardent Health by 574.9% in the 1st quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock worth $550,000 after acquiring an additional 34,276 shares during the period. Finally, Geode Capital Management LLC boosted its stake in Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,769 shares in the last quarter.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.